Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent 2024 preliminary results and restructuring ...
Hosted on MSN1mon
Reasons to Retain PacBio Stock in Your Portfolio for NowIntegrating Onso into 10X workflows supports single-cell and spatial biology applications, addressing fast-growing market needs. Mixed Q3 Results: PacBio exited the third quarter of 2024 with ...
(RTTNews) - PacBio (PACB), Tuesday announced preliminary revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154.0 million representing a year-over-year decline of 33% ...
PacBio’s earnings surpassed the Zacks Consensus ... which is the first SBB short-read sequencing service provider. Joining the 10X Genomics Compatible Partner program integrates Onso into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback